HomeALRN • NASDAQ
add
Aileron Therapeutics Inc
Previous close
$1.93
Day range
$1.96 - $2.17
Year range
$1.61 - $7.42
Market cap
45.72M USD
Avg Volume
116.02K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.07M | 207.08% |
Net income | -5.85M | -220.03% |
Net profit margin | — | — |
Earnings per share | -0.27 | 32.67% |
EBITDA | -6.07M | -208.96% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.65M | 46.26% |
Total assets | 104.22M | 712.80% |
Total liabilities | 8.98M | 453.26% |
Total equity | 95.23M | — |
Shares outstanding | 21.67M | — |
Price to book | 0.83 | — |
Return on assets | -14.21% | — |
Return on capital | -15.47% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -5.85M | -220.03% |
Cash from operations | -3.82M | -132.87% |
Cash from investing | — | — |
Cash from financing | -446.00K | — |
Net change in cash | -4.26M | -288.43% |
Free cash flow | -2.35M | -134.12% |
About
Founded
2001
Headquarters
Website
Employees
15
